45 Followers SGX:42C - iX Biopharma Ltd IX Biopharma
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)


Singapore shares open higher on Wednesday, tracking Wall Street rally; STI up 1%

15 Jul 2020 - The Business Times
SINGAPORE shares opened stronger on Wednesday, tracking a Wall Street rally overnight, with the benchmark Straits Times Index (STI) rising 26.19 points or 1 per cent to 2,646.38 as at 9.01am. The STI ended lower on Tuesday, as sentiment was dampened by advanced estimates that showed Singapore's second-quarter ...
sgx:c52 klse:1503 sgx:42c sgx:8yy sgx:tq5 sgx:1h3 sgx:nc2 sgx:u96 sgx:o39 sgx:s68 sgx:d05 sgx:f17 klse:0080 sgx:g07 sgx:j36

STI drifts 10.89 points lower to 2,620.19 after Q2 GDP advance estimates, pharma stocks jump

14 Jul 2020 - The Business Times
REGIONAL markets were broadly softer on Tuesday, following an overnight dip in US technology heavyweights that weighed on the S&P500 index. In Singapore, sentiment was also dampened by advance estimates that showed that Q2 GDP shrank 41.2 per cent on a quarter-on-quarter basis, versus a contraction of ...
sgx:42c sgx:z74 sgx:1j5 klse:0080

Stocks to watch: ComfortDelGro, Koufu, DBS, Lian Beng, SLB, Geo Energy

26 May 2020 - The Business Times
THE following companies saw new developments that may affect trading of their securities on Tuesday: ComfortDelGro Corporation: The transport giant's net profit fell 48.9 per cent on year to S$36 million for the first quarter ended March 31, hit by weak ridership amid Covid-19-induced lockdowns in the ...
sgx:c52 sgx:l03 sgx:re4 sgx:vl6 sgx:42c sgx:s68 sgx:d05

Healthcare-related stocks averaged 37% gains in YTD 2020

19 May 2020 - Singapore Business Review
They made it to the city’s top 200 stocks by daily turnover. Singapore’s most traded primary-listed stocks that represent medical equipment manufacturing, biotech and pharmaceuticals all generated gains as of 15 May, averaging 37% gains, according to data from SGX. Listed on the Catalist, the three healthcare-related ...
sgx:42c sgx:s68 sgx:8yy sgx:1j5 lse:jd

Singapore shares pare previous day's gains; STI down 0.2% at open

29 Apr 2020 - The Business Times
SINGAPORE stocks opened weaker on Wednesday following overnight losses in the US and the release of the Monetary Authority of Singapore's (MAS) half-year report. The benchmark Straits Times Index (STI) headed down 0.2 per cent or 5.6 points to 2,557.35 as at 9.03am on Wednesday, reversing its previous ...
sgx:a17u sgx:awx klse:7146 sgx:n2iu sgx:5wh sgx:42c sgx:o39 sgx:u11 sgx:d05 klse:0080

iX Biopharma inks supply agreement with Cannatrek to supply medicinal cannabis wafer in Australia

29 Apr 2020 - The Edge Markets
SINGAPORE (Apr 29): iX Biopharma has entered into a supply agreement with Cannatrek, a medical cannabis enterprise, to supply Xativa, the world’s first freeze-dried sublingual medicinal cannabis wafer in Australia. The agreement, which was signed by iX Biopharma’s wholly-owned subsidiary, iX Syrinx, ...
sgx:42c

iX Biopharma enters China market with licensing agreement for erectile dysfunction drug

27 Apr 2020 - The Edge Markets
SINGAPORE (Apr 27): iX Biopharma has entered into a 10-year licensing agreement with Yiling Pharmaceutical in China for the licensing, supply, and distribution of Wafesil, a fast-dissolving sublingual sildenafil wafer for the treatment of male erectile dysfunction. See also: iXBiopharma's Wafesil granted ...
sgx:42c

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms